Literature DB >> 4600292

Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.

A S Brickman, J W Coburn, A W Norman, S G Massry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4600292     DOI： 10.1016/0002-9343(74)90764-5

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  3 in total

1.  Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog.

Authors:  W E Rutherford; P Bordier; P Marie; K Hruska; H Harter; A Greenwalt; J Blondin; J Haddad; N Bricker; E Slatopolsky
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

2.  Seasonal variations in urinary excretion of calcium and magnesium in healthy subjects and patients with renal calculus and chronic renal failure.

Authors:  J Głuszek; B Raszeja-Wanic; S Grajek; Z Kwias; T Ratajczak; C Smarsz
Journal:  Int Urol Nephrol       Date:  1978       Impact factor: 2.370

3.  Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.

Authors:  C Velentzas; D G Oreopoulos; A Pierratos; H E Meema; S Rabinovich; H Meindok; H Husdan; T M Murray; R Ogilvie; A Katirtzoglou
Journal:  Can Med Assoc J       Date:  1981-03-01       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.